YKHC Low-Risk Endoscopy Criteria: Difference between revisions
From Guide to YKHC Medical Practices
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
Because YKHC has no ICU, serious endoscopy complications require Medevac transfer. Prevention of this occurrence is a priority. Therefore endoscopy in Bethel is limited to relatively low risk patients. | Because YKHC has no ICU, serious endoscopy complications require Medevac transfer. Prevention of this occurrence is a priority. Therefore endoscopy in Bethel is limited to relatively low risk patients. | ||
The intention of this page is to provide transparent criteria for the most common comorbidities which increase the risk of an endoscopy complication. This page is not all-inclusive. | |||
These criteria are written with isolated diagnoses in mind. The presence of multiple comorbidities may yield a higher risk than either individually and this effect is not incorporated into these criteria. | |||
Revision as of 01:14, 11 October 2017
OVERVIEW
Because YKHC has no ICU, serious endoscopy complications require Medevac transfer. Prevention of this occurrence is a priority. Therefore endoscopy in Bethel is limited to relatively low risk patients.
The intention of this page is to provide transparent criteria for the most common comorbidities which increase the risk of an endoscopy complication. This page is not all-inclusive.
These criteria are written with isolated diagnoses in mind. The presence of multiple comorbidities may yield a higher risk than either individually and this effect is not incorporated into these criteria.
GENERAL
BMI
- BMI < 45 (non-negotiable limit)
- For BMI 35-45, consult anesthesia
CARDIAC
CHF
- Most recent LVEF >= 40%
- Recent (<6mos) BNP <= 125 pg/mL (or YKHC laboratory’s current upper limit of normal)
- No loop diuretic use (chronic or acute) within the last 12 months
CAD
- No history of coronary revascularization (either surgical or endovascular)
- No use of anti-angina agents in the last 12 months
- Normal exercise treadmill test within the last 12 months
PULMONARY
COPD
Post-bronchodilator FEV1 >= 60% of predicted